Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EK4242 / 2||- / -|
Administered by: Other Purchased by: ??
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Arterial disorder (heart diseases and arteries including heart failure); Diabetes; Disorder lung; Heart disorder (heart diseases and arteries including heart failure); Heart failure; Hypertension; Kidney disorder; Obesity
Diagnostic Lab Data:
CDC 'Split Type': ILPFIZER INC2021330457
Write-up: was found dead in his home; This is a spontaneous report from a non-contactable other healthcare professional (HCP) via regulatory authority. A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose via an unspecified route of administration on an unspecified date (batch/lot number: EK4242) as a single dose for COVID-19 immunisation. Medical history included hypertension, heart diseases and arteries including heart failure, lung diseases, kidney diseases, diabetes, obesity. The patient''s concomitant medications were not reported. The patient was found dead in his home on an unspecified date. Time range reported as 3 days. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: The limited information provided in this report does not allow a full assessment of the case. The event "death" with unknown cause is assessed as related to the suspect drug per company guidance. Medical history of hypertension, heart diseases and arteries including heart failure, lung diseases, kidney diseases, diabetes, obesity may provide plausible explanations for the event. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : IL-PFIZER INC-2020517122 same drug and event, different patient; Reported Cause(s) of Death: was found dead in his home
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166